v3.26.1
Summary of Significant Accounting Policies (Tables)
 9 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Schedule of Restrictions on Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
June 30,
2026		June 30,
2025
Cash and cash equivalents$476 $350 
Restricted cash47 20 
Cash, cash equivalents and restricted cash$523 $370 
Schedule of Cash and Cash Equivalents The following table provides a reconciliation of the total cash, cash equivalents and restricted cash reported on the Condensed Consolidated Balance Sheets to the corresponding amounts reported on the Condensed Consolidated Statements of Cash Flows.
June 30,
2026		June 30,
2025
Cash and cash equivalents$476 $350 
Restricted cash47 20 
Cash, cash equivalents and restricted cash$523 $370 
Schedule of Shares Used in Computing Basic and Diluted Earnings Per Share Shares used in computing basic and diluted earnings per share are as follows: 
Three Months Ended
June 30,		Nine Months Ended
June 30,
2026202520262025
Denominator (thousands of shares):
Weighted-average common shares outstanding — basic214,690 214,813 214,789 214,896 
Incremental shares issuable for stock options, and common stock awards(a)— — 1,048 746 
UGI Corporation Senior Notes (a) (b)— — 5,950 2,781 
Weighted-average common shares outstanding — diluted214,690 214,813 221,787 218,423 
(a)For the three months ended June 30, 2026 and 2025, 6,546 and 5,853 shares, respectively, have been excluded from the computation of diluted earnings per share as such incremental shares would be antidilutive due to the net losses for the periods. For the nine months ended June 30, 2026 and 2025, there were 5,555 and 5,212 shares, respectively, associated with outstanding stock option awards that were not included in the computation of diluted earnings per share above because their effect was antidilutive.
(b)See Note 8 for additional information on the UGI Corporation Senior Notes.